Improved care through syndromic testing with the BioFire^® Respiratory 2.1plus Panel

 Faster Time to Results.

The BioFire^® Respiratory 2.1 plus (RP2.1plus) Panel can dramatically reduce time to diagnosis compared to traditional testing methods.^{1,2,3,4,5,6,7}

 Improved Patient Management

Improved care management regarding admissions, isolations, cohorting, and discharges with the BioFire^® Respiratory 2.1 plus (RP2.1plus) Panel

 Targeted Treatment Decisions

Targeted testing runs the risk of missing the true causative agent. Fast, accurate results give you the confidence to reduce antibiotic use^{8,9,10,11,12,13} or use neuraminidase inhibitors more appropriately.^9,11,12

Learn more

1. Martinez RM. Implementation of non-batched respiratory virus assay significantly impacts patient outcomes in the ICU, CVS 2016.
2. Rogers, BB. OA. Impact of a Rapid Respiratory Panel Test on Patient Outcomes. Arch Pathol Lab Med 2014.
3. Xu M et al. Implementation of Filmarray respiratory viral panel in a core laboratory improves testing turnaround time and patient care. Am J Clin Pathol. 2013(1);139:118-123.
4. Poelman R, et al. Future Microbiol. 2020 May;15:623-632.
5. Pettit N., et al. J. Med Microbiol., March 2015 64:312-313.
6. Gelfer G et al. Diag Micro Infect Dis. 2015;83:400-406.
7. Rappo U et al. J. Clin. Microbiol. JCM.00549-16; Accepted manuscript posted online 25 May 2016.
8. Subramony A et al. J Pediatr. 2016; doi:10.1016/j.jpeds.2016.02.050.
9. Brendish N, et al. Lancet Respir Med. Published Online April 5, 2017.
10. McFall, et al., Clinical Pediatrics. 2017 Feb; Published online November 2, 2017.
11. Lee BR, et al., Journal of Clinical Virology, 2018; 110:11-16.
12. Echavarria Met al. J Clin Virol. 2018 Sep; 108:90-95.
13. Roy K et al. West Hertfordshire Hospitals (ERS poster Sep 2018).